🔗 Share this article

This year's Nobel Prize in medical science was granted for transformative discoveries that clarify how the immune system attacks harmful pathogens while protecting the body's own cells.

A trio of esteemed researchers—from Japan Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their work identified specialized "sentinels" within the defense system that remove malfunctioning defense cells capable of harming the body.

The findings are now paving the way for innovative therapies for immune disorders and cancer.

The laureates will divide a monetary award valued at 11m SEK.

Decisive Discoveries

"The work has been essential for comprehending how the body's defenses operates and why we do not all develop serious autoimmune diseases," commented the head of the award panel.

The trio's studies address a core question: How does the immune system defend us from countless infections while leaving our healthy cells unharmed?

The body's protection system employs white blood cells that search for signs of infection, even viruses and germs it has never encountered.

Such defenders employ detectors—called recognition units—that are produced by chance in a vast number of combinations.

That provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the process unavoidably produces immune cells that may attack the body.

Protectors of the Immune System

Scientists previously understood that some of these harmful defense cells were destroyed in the immune organ—where white blood cells develop.

This year's Nobel Prize recognizes the identification of T-reg cells—known as the immune system's "peacekeepers"—which patrol the system to disarm other immune cells that attack the body's own tissues.

We know that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee added, "The findings have established a new field of research and spurred the creation of new treatments, for example for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the system from fighting the tumor, so studies are aimed at lowering their quantity.

In autoimmune diseases, experiments are testing boosting T-reg cells so the organism is no longer being harmed. A comparable approach could also be effective in reducing the chances of transplanted organ failure.

Pioneering Studies

Prof Sakaguchi, from Osaka University, conducted experiments on rodents that had their immune gland extracted, causing self-attack conditions.

He demonstrated that injecting defense cells from healthy mice could prevent the illness—suggesting there was a system for preventing defenders from harming the host.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in rodents and humans that resulted in the discovery of a gene critical for the way T-regs operate.

"The groundbreaking work has uncovered how the body's defenses is controlled by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a prominent physiology expert.

"This research is a remarkable illustration of how fundamental biological research can have broad consequences for public health."